TAE Technologies

APrivate (proposed TMTG merger)Founded 1998🇺🇸Foothill Ranch, California

CEO

Michl Binderbauer

Overview

TAE Technologies is a private fusion company developing hydrogen-boron fusion with a beam-driven field-reversed-configuration architecture. Its 2025 'Norm' breakthrough reduced reactor complexity enough to skip the planned Copernicus step and move directly toward Da Vinci, its first prototype power plant, while TAE Power Solutions and TAE Life Sciences commercialize adjacent power-delivery and oncology technologies derived from its fusion R&D.

Main Products

Norm

Operational

TAE's streamlined fusion research machine that forms field-reversed-configuration plasmas using only neutral beam injection, reducing reactor size, complexity, and cost versus Norman while preserving the path to commercial hydrogen-boron fusion.

Operational in Foothill Ranch, California. Norm routinely delivers TAE's highest plasma performance and is being upgraded to 100 million degrees Celsius.

Plasma Temperature70+ million °C

Machine Length~12 m / 40 ft

ConfigurationNBI-only FRC

Da Vinci

In Development

TAE's first prototype commercial fusion power plant, designed to deliver net electrons to the grid from the company's hydrogen-boron fusion pathway and serve as the bridge to later utility-scale plants.

Pre-construction. TAE is running a multi-state site-selection process in 2026 and says construction would begin after required approvals and closing of the proposed merger. Grid delivery remains targeted for the early 2030s.

Target Output50 MWe

Future Plant Scale350-500 MWe

Target OperationEarly 2030s

What's Next

Close the proposed TMTG merger

Obtain approvals and satisfy closing conditions on the proposed all-stock TMTG transaction, which TAE says would help fund construction of its first fusion power plant.

Mid-2026

Finalize the first plant site

Complete site selection and development planning for TAE's initial 50 MWe fusion facility after its 2026 multi-state evaluation process.

2026

Upgrade Norm to 100 million °C

Push the current experimental platform from 70+ million °C toward 100 million °C to validate operating modes and hardware for TAE's next-generation reactors.

2026–2027

Da Vinci grid power delivery

Deliver first fusion-generated electricity to the grid from Da Vinci, establishing TAE as a commercial fusion power provider.

Early 2030s

Operations & Revenue

StatusPre-revenue in fusion

Norm is operational and being upgraded toward 100 million degrees Celsius, while TAE is advancing site selection for its first 50 MWe fusion plant. Commercial fusion revenue remains an early-2030s target; adjacent subsidiaries already commercialize power-delivery and oncology technologies.

Revenue Streams

TAE Power Solutions

Subsidiary commercializing power-delivery and battery energy-storage systems originally built for TAE's fusion program, including EV powertrains and stationary storage applications.

TAE Life Sciences

Subsidiary developing boron neutron capture therapy platforms and related drugs for complex cancers using accelerator technology adapted from TAE's fusion R&D.

Key Metrics

Employees

~400

Est. Annual Revenue

Pre-revenue in fusion; near-term commercialization is centered on TAE Power Solutions and TAE Life Sciences

Total Funding

>$1.3B

Granted Patents

>1,600

Norm Plasma Temperature

70+ million °C

Da Vinci Initial Output

~50 MWe

Timeline

2026First plant siting process advances

TAE completes a multi-state site-evaluation tour across Alabama, Ohio, and Texas as it prepares locations for its first fusion power plant.

2025Norm breakthrough published

TAE publishes its Nature Communications breakthrough showing FRC plasma formation using only neutral beam injection, creating the simpler 'Norm' machine.

2025Latest funding round

Raises more than $150M from investors including Chevron Technology Ventures, Google, and NEA, taking total equity capital raised since inception to more than $1.3B.

2025Copernicus removed from roadmap

TAE says Norm's performance is strong enough to leapfrog the planned Copernicus machine and move directly toward Da Vinci.

2025TMTG merger announced

TAE signs a definitive agreement to merge with Trump Media & Technology Group in an all-stock transaction valued at more than $6B, subject to approvals and closing conditions.

2022Norman exceeds goals by 250%

TAE says Norman sustained plasma above 75 million degrees Celsius, 250% above its original goal, while closing a $250M Series G-2 round.

2021$280M financing after 50M+ C milestone

TAE raises an additional $280M after demonstrating stable plasmas above 50 million degrees Celsius on Norman.

2017Norman first plasma

TAE's fifth-generation C-2W machine, later named Norman, achieves first plasma as the company continues its transition from Tri Alpha Energy to TAE Technologies.

2015Plasma confinement milestone

TAE says its C-2U machine kept an FRC plasma confined at operator will, validating the 'long enough' part of its fusion roadmap.

1998Founded as Tri Alpha Energy

Founded in 1998 as Colliding Beam Fusion Reactor Inc., later operating as Tri Alpha Energy before becoming TAE Technologies.

Funding

Round	Date	Amount	Investors
Funding Round	2021	$280M	Google, NEA, and other new and existing investors
Series G-2	2022	$250M	Google, Chevron, Reimagined Ventures, Sumitomo Corporation of Americas, TIFF Investment Management, and others
Funding Round	2025	>$150M	Google, Chevron Technology Ventures, NEA